Please login to the form below

Not currently logged in

Alliance Pharma appoints two European country managers

Dr Philippe Pasdelou and Lars Börger join the UK-based specialty pharma firm

UK specialty company Alliance Pharma has appointed two new country managers.

Dr Philippe Pasdelou will manage operations in France, while Lars Börger will lead the company's teams in Germany, Switzerland and Austria.

At the same time the company announced its acquisition of three antimalarial drugs from AstraZeneca for £4.2m and up to £1m in future sales royalties.

The brands – Paludrine, Avoclor and Savarine – are sold predominately in the UK and France and are expected to generate approximately £1.1m per year to Alliance's balance sheet.

“We are delighted to add these important antimalarial brands to the Alliance portfolio, and at the same time to have appointed such highly experienced executives as Philippe Pasdelou and Lars Börger to spearhead our expansion in mainland Europe,” said John Dawson, chief executive of Alliance Pharma.

The company said both Pasdelou and Börger would initially focus on securing acquisition and in-licensing opportunities across Europe.

Börger was most recently licensing director at Grünenthal and has experience across a number of pharmaceutical and medical device companies, in both strategic and operational roles.

Meanwhile, Pasdelou has managed several pharmaceutical companies in France and other countries and his experience includes setting up a company with a similar business model to Alliance.

14th August 2012


Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...